Abstract
There are currently 26 modern antibody-based therapeutic agents approved by the US and EU, with 500 more products in the global development pipeline. Total market value of these therapeutics could reach more than $17 billion by the close of 2010. This market overview includes all 26 products (plus two that were withdrawn) and their originators, their therapeutic indications, and their approval records.
| Original language | English |
|---|---|
| Pages (from-to) | 18-25 |
| Number of pages | 8 |
| Journal | BioPharm International |
| Volume | 17 |
| Issue number | 12 |
| Publication status | Published - Dec 2004 |